Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar

Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar

Objectives To evaluate an intervention to reduce the nocebo effect (NE) when switching from the originator infliximab (OI) to the infliximab biosimilar SB2 in chronic inflammatory rheumatic disease (CIRD).Methods An intervention was built with healthcare professionals (HPs) and a patient representat...

Full description

Bibliographic Details
Main Authors: Catherine Beauvais, Marie Antignac, Sandra Desouches, Juliette Petit, Rose-Marie Poilverd, Régine Baratto, Sylvie Darthout, Karine Louati, Nathalie Deparis
Format: Article
Language:English
Published: BMJ Publishing Group 2021-04-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/7/1/e001396.full

Internet

https://rmdopen.bmj.com/content/7/1/e001396.full

Similar Items